AAAAAA
Results:
1-20
|
Results: 20
Authors:
Yamauchi, T
Nowak, BJ
Keating, MJ
Plunkett, W
Citation: T. Yamauchi et al., DNA repair initiated in chronic. lymphocytic leukemia lymphocytes by 4-hydroperoxycyclophosphamide is inhibited by fludarabine and clofarabine, CLIN CANC R, 7(11), 2001, pp. 3580-3589
Authors:
Sampath, D
Plunkett, W
Citation: D. Sampath et W. Plunkett, Design of new anticancer therapies targeting cell cycle checkpoint pathways, CURR OPIN O, 13(6), 2001, pp. 484-490
Authors:
Gandhi, V
Plunkett, W
Weller, S
Du, M
Ayres, M
Rodriguez, CO
Ramakrishna, P
Rosner, GL
Hodge, JP
O'Brien, S
Keating, MJ
Citation: V. Gandhi et al., Evaluation of the combination of nelarabine and fludarabine in leukemias: Clinical response, pharmacokinetics, and pharmacodynamics in leukemia cells, J CL ONCOL, 19(8), 2001, pp. 2142-2152
Authors:
Azuma, A
Huang, P
Matsuda, A
Plunkett, W
Citation: A. Azuma et al., 2 '-C-cyano-2 '-deoxy-1-beta-D-arabino-pentofuranosylcytosine: A novel anticancer nucleoside analog that causes both DNA strand breaks and G(2) arrest, MOLEC PHARM, 59(4), 2001, pp. 725-731
Authors:
Shi, Z
Azuma, A
Sampath, D
Li, YX
Huang, P
Plunkett, W
Citation: Z. Shi et al., S-phase arrest by nucleoside analogues and abrogation of survival without cell cycle progression by 7-hydroxystaurosporine, CANCER RES, 61(3), 2001, pp. 1065-1072
Authors:
Azuma, A
Huang, P
Matsuda, A
Plunkett, W
Citation: A. Azuma et al., Cellular pharmacokinetics and pharmacodynamics of the deoxycytidine analog2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine (CNDAC), BIOCH PHARM, 61(12), 2001, pp. 1497-1507
Authors:
Rodriguez, CO
Plunkett, W
Paff, MT
Du, M
Nowak, B
Ramakrishna, P
Keating, MJ
Gandhi, V
Citation: Co. Rodriguez et al., High-performance liquid chromatography method for the determination and quantitation of arabinosylguanine triphosphate and fludarabine triphosphate in human cells, J CHROMAT B, 745(2), 2000, pp. 421-430
Authors:
Feng, L
Achanta, G
Pelicano, H
Zhang, W
Plunkett, W
Huang, P
Citation: L. Feng et al., Role of p53 in cellular response to anticancer nucleoside analog-induced DNA damage, INT J MOL M, 5(6), 2000, pp. 597-604
Authors:
Yang, LY
Li, L
Jiang, H
Shen, Y
Plunkett, W
Citation: Ly. Yang et al., Expression of ERCC1 antisense RNA abrogates gemcitabine-mediated cytotoxicsynergism with cisplatin in human colon tumor cells defective in mismatch repair but proficient in nucleotide excision repair, CLIN CANC R, 6(3), 2000, pp. 773-781
Authors:
Huang, P
Sandoval, A
Van Den Neste, E
Keating, MJ
Plunkett, W
Citation: P. Huang et al., Inhibition of RNA transcription: a biochemical mechanism of action againstchronic lymphocytic leukemia cells by fludarabine, LEUKEMIA, 14(8), 2000, pp. 1405-1413
Authors:
Kisor, DF
Plunkett, W
Kurtzberg, J
Mitchell, B
Hodge, JP
Ernst, T
Keating, MJ
Gandhi, V
Citation: Df. Kisor et al., Pharmacokinetics of nelarabine and 9-beta-D-arabinofuranosyl guanine in pediatric and adult patients during a phase I study of nelarabine for the treatment of refractory hematologic malignancies, J CL ONCOL, 18(5), 2000, pp. 995-1003
Authors:
Esteva, FJ
Soh, LT
Holmes, FA
Plunkett, W
Meyers, CA
Forman, AD
Hortobagyi, GN
Citation: Fj. Esteva et al., Phase II trial and pharmacokinetic evaluation of cytosine arabinoside for leptomeningeal metastases from breast cancer, CANC CHEMOT, 46(5), 2000, pp. 382-386
Authors:
Delauter, BJ
Ramanathan, RK
Egorin, MJ
Stover, LL
Zuhowski, EG
Plunkett, W
Zamboni, WC
Citation: Bj. Delauter et al., Pharmacokinetics of gemcitabine and 2 ',2 '-difluorodeoxyuridine in a patient with ascites, PHARMACOTHE, 20(10), 2000, pp. 1204-1207
Authors:
Huang, P
Feng, L
Oldham, EA
Keating, MJ
Plunkett, W
Citation: P. Huang et al., Superoxide dismutase as a target for the selective killing of cancer cells, NATURE, 407(6802), 2000, pp. 390-395
Authors:
Genini, D
Budihardjo, I
Plunkett, W
Wang, XD
Carrera, CJ
Cottam, HB
Carson, DA
Leoni, LM
Citation: D. Genini et al., Nucleotide requirements for the in vitro activation of the apoptosis protein-activating factor-1-mediated caspase pathway, J BIOL CHEM, 275(1), 2000, pp. 29-34
Authors:
Sampath, D
Plunkett, W
Citation: D. Sampath et W. Plunkett, The role of c-jun kinase in the apoptotic response to nucleoside analogue-induced DNA damage, CANCER RES, 60(22), 2000, pp. 6408-6415
Authors:
Giles, FJ
O'Brien, SM
Santini, V
Gandhi, V
Plunkett, W
Seymour, JF
Robertson, LE
Kantarjian, HM
Keating, MJ
Citation: Fj. Giles et al., Sequential cis-platinum and fludarabine with or without arabinosyl cytosine in patients failing prior fludarabine therapy for chronic lymphocytic leukemia: A phase II study, LEUK LYMPH, 36(1-2), 1999, pp. 57-65
Authors:
Wilhelm, M
O'Brien, S
Rios, MB
Estey, E
Keating, MJ
Plunkett, W
Sorenson, M
Kantarjian, HM
Citation: M. Wilhelm et al., Phase I study of arabinosyl-5-azacytidine (Fazarabine) in adult acute leukemia and chronic myelogenous leukemia in elastic phase, LEUK LYMPH, 34(5-6), 1999, pp. 511-518
Authors:
Milas, L
Fujii, T
Hunter, N
Elshaikh, M
Mason, K
Plunkett, W
Ang, KK
Hittelman, W
Citation: L. Milas et al., Enhancement of tumor radioresponse in vivo by gemcitabine, CANCER RES, 59(1), 1999, pp. 107-114
Authors:
Aguayo, A
Cortes, JE
Kantarjian, HM
Beran, M
Gandhi, V
Plunkett, W
Kurtzberg, J
Keating, MJ
Citation: A. Aguayo et al., Complete hematologic and cytogenetic response to 2-amino-9-beta-D-arabinosyl-6-methoxy-9H-guanine in a patient with chronic myelogeneous leukemia in T-cell blastic phase - A case report and review of the literature, CANCER, 85(1), 1999, pp. 58-64
Risultati:
1-20
|